interventional cardiology,drug-eluting stent
Adjust Font Size: Decrease Increase
The MiStent® SES is a CE Marked drug-eluting stent that has been designed to optimize healing. Read more.
December 9, 2015 — Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial against Xience
Read more.
October 13, 2015 — Positive Four-Year Clinical Data from Micell Technologies' MiStent SES Presented at TCT 2015
Read more.
Micell Technologies is bringing together the clinical advantages of a drug-eluting stent with the long-term safety and stability of a bare metal stent. The resulting drug-delivery device is intended to redefine the field of interventional cardiology. Read more.
Micell published in the October 2013 issue of JACC Cardiovascular Interventions. Read more..
Micell published in the Journal of Controlled Release on the enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug. Read more.
Caution: The MiStent SES has received CE marking but is not approved in the USA or any other countries. Any other products described on this website are investigational devices that are not available for sale in any country.
Home | About Us | Therapeutic Focus | Product Pipeline | Technology | News | Terms of Use | Privacy Policy | Site Map
© 2016 Micell Technologies, Inc. All rights reserved.
"Micell", "MiStent", and "MiStent SES" are registered trademarks of Micell Technologies, Inc.